Please assess the completion status of the following clinical trial:

Trial Title: Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Between the age of 5 and 18 years old~* Clinical diagnosis of Stargardt Disease~* Molecular confirmation of Stargardt Disease (with 2 identified mutations in ABCA4)~* Visual acuity better than 20/100~Exclusion Criteria:~* Limited central vision, defined as visual acuity worse than 20/100~* A diagnosis of any other retinal degenerative disease

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).